Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation

Pharmacological Research

Volumn 58, Issue 3-4, 2008, Pages 232-239

  Mamedova, Liaman K ^a,b   Wang, Ruibo ^c   Besada, Pedro ^a   Liang, Bruce T ^c   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

G protein coupled receptor; Ischemia; Skeletal muscle; Tumor necrosis factor; UDP; Uracil nucleotide

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; G PROTEIN COUPLED RECEPTOR; HEMATOXYLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROPIDIUM IODIDE; PURINERGIC P2Y6 RECEPTOR; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; URIDINE DIPHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; HISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SKELETAL MUSCLE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; HINDLIMB; IMMUNOHISTOCHEMISTRY; MICE; MUSCLE, SKELETAL; PROTECTIVE AGENTS; RECEPTORS, PURINERGIC P2; REGIONAL BLOOD FLOW; REPERFUSION INJURY; URIDINE DIPHOSPHATE;

EID: 54349093967     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.08.004     Document Type: Article

References (29)

1. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., et al. International Union of Pharmacology LVIII. Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58 (2006) 281-341
2. 6 receptor. J Med Chem 49 (2006) 5532-5543
3. 6 receptors. J Med Chem 49 (2006) 7076-7087
4. 6 nucleotide receptors. Biochem Pharmacol 67 (2004) 1763-1770
5. 4 nucleotide receptors. Biochem Pharmacol 65 (2003) 923-931
6. Korcok J., Raimundo L.N., Du X., Sims S.M., and Dixon S.J. P2Y6 nucleotide receptors activate NF-κB and increase survival of osteoclasts. J Biol Chem 280 (2005) 16909-16915
7. - secretion in mouse trachea. Cell Physiol Biochem 16 (2005) 99-108
8. 6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. Biochem Biophys Res Commun 330 (2005) 467-473
9. 6 signaling pathway. Blood 107 (2006) 2936-2942
10. 6 receptors. Am J Physiol Heart Circ Physiol 282 (2002) H784-H792
11. Franke H., Krugel U., and Illes P. P2 receptors and neuronal injury. Pflugers Arch 452 (2006) 622-644
12. 6 nucleotide receptor activates PKC to protect 1321N1 astrocytoma cells against tumor necrosis factor-induced apoptosis. Cell Mol Neurobiol 23 (2003) 410-418
13. 12 receptors. Biochem Pharmacol 72 (2006) 1031-1041
14. Sandri M., and Carraro U. Apoptosis of skeletal muscles during development and disease. Int J Biochem Cell Biol 31 (1999) 1373-1390
15. SAS Institute. SAS guide for personal computers-Version 6.07 (1995), SAS Institute, Cary, NC
16. 3 receptors: attenuation of skeletal muscle ischemia and reperfusion injury. Am J Physiol 293 (2007) 3685-3691
17. Durbeej M., Sawatzki S.M., Barresi R., Schmainda K.M., Allamand V., Michele D.E., et al. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy. Proc Natl Acad Sci USA 100 (2003) 8910-8915
18. Shen J.B., Cronin C., Sonin D., Joshi B.V., Nieto M.G., Harrison D., et al. P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy. Implications for the treatment of heart failure. Am J Physiol Heart Circ Physiol 292 (2007) 1077-1084
19. Duclos F., Straub V., Moore S.A., Venzke D.P., Hrstka R.F., Crosbie R.H., et al. Progressive muscular dystrophy in α-sarcoglycan-deficient mice. J Cell Biol 142 (1998) 1461-1471
20. Zimmet J., Järlebark L., Hammarberg T., van Galen P.J.M., Jacobson K.A., and Heilbronn E. Synthesis and biological activity of novel 2-thio derivatives of ATP. Nucleosides Nucleotides 12 (1993) 1-20
21. Banachewicz W., Suplat D., Krzeminski P., Pomorski P., and Barfanska J. P2 nucleotide receptors on C2C12 satellite cells. Purinergic Signal 1 (2005) 249-257
22. 1 receptor of human platelets. J Thromb Haemost 4 (2006) 861-868
23. Stabel S., and Parker P.J. Protein kinase C. Pharmacol Ther 51 (1991) 71-95
24. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9 (1995) 484-496
25. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
26. Stewart C.E.H., Newcomb P.V., and Holly J.M.P. Multifaceted roles of TNF-α in myoblast destruction: a multitude of signal transduction pathways. J Cell Physiol 198 (2004) 237-247
27. Bar-Shai M., and Reznick A.Z. Reactive nitrogen species induce nuclear factor-kappaB-mediated protein degradation in skeletal muscle cells. Free Radic Biol Med 40 (2006) 2112-2125
28. Armstrong S., Korcok J., Sims S.M., and Dixon S.J. Activation of transcription factors by extracellular nucleotides in immune and related cell types. Purinergic Signal 3 (2007) 59-69
29. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912